COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9

RING NUCLEASE

HTRA1 MODULATION FOR TREATMENT OF AMD

COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID

METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS

ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOF

METHODS FOR MODIFYING PLASTID GENOMES

CRISPR SYSTEMS IN PLANTS

METHODS FOR CIRCULARIZING LINEAR DOUBLE STRANDED NUCLEIC ACIDS

TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES

CHROMATIN REMODELERS TO ENHANCE TARGETED GENE ACTIVATION

Base editing of PCSK9 and methods of using same for treatment of disease

MODIFIED CRISPR RNA AND MODIFIED SINGLE CRISPR RNA AND USES THEREOF

ENZYME COMPOSITIONS AND USES THEREOF

CHEMICALLY MODIFIED GUIDE RNAS FOR GENOME EDITING WITH CAS9

GENE EDITING OF MONOGENIC DISORDERS IN HUMAN HEMATOPOIETIC STEM CELLS -- CORRECTION OF X-LINKED HYPER-IGM SYNDROME (XHIM)

SAFE HARBOR LOCI

METHODS AND COMPOSITIONS FOR IMPROVING PLANT ARCHITECTURE AND YIELD TRAITS

DIRECT REPLACEMENT GENOME EDITING

APPLICATION OF MAL33 GENE DELETION IN IMPROVING TOLERANCE OF SACCHAROMYCES CEREVISIAE TO INHIBITORS IN THE LIGNOCELLULOSE HYDROLYZATES

COMPOSITIONS AND METHODS FOR ENHANCING HOMOLOGOUS RECOMBINATION

Transposase polypeptides and uses thereof

GENOME EDITING USING CAS9 OR CAS9 VARIANT

ZINC FINGER DEGRADATION DOMAINS

METHOD FOR SPECIFICALLY EDITING GENOMIC DNA AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR EXPRESSING FACTOR IX FOR HEMOPHILIA B THERAPY

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

GENOME ENGINEERING USING CRISPR RNA-GUIDED INTEGRASES

GENOME ENGINEERING METHOD AND GENOME ENGINEERING KIT

Modified excisable MON87701 soybean transgenic insect resistance locus

COMPOSITIONS AND METHODS FOR INHIBITION AND TARGETING OF P97

Kinetically enhanced engineered FnCas9 and its uses thereof

FNCPF1 MUTANT FOR BROAD-SPECTRUM IDENTIFICATION ON PAM SEQUENCE ANS USE THEREOF

POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYN-DROMES

CELL-PENETRATING PEPTIDE AND USE THEREOF

METHODS OF EDITING A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE

FORMULATIONS

SHUTTLE VECTOR FOR EXPRESSION IN E. COLI AND BACILLI

TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE FOR THERAPY

NOVEL MUTATIONS THAT ENHANCE THE DNA CLEAVAGE ACTIVITY OF ACIDAMINOCOCCUS SP. CPF1

METHODS, COMPOSITIONS AND COMPONENTS FOR CRISPR-CAS9 EDITING OF CBLB IN T CELLS FOR IMMUNOTHERAPY

NUCLEASE-MEDIATED PLASMID INTEGRATION

CRISPR-CAS12i systems

Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

UBIQUITIN VARIANTS WITH IMPROVED AFFINITY FOR 53BP1

CHEMICALLY MODIFIED GUIDE RNAS FOR GENOME EDITING WITH CAS12B

DETECTION OF GENE LOCI WITH POLYCHROMATIC CRISPR-ASSOCIATED PROTEIN 9

Amino Acid Mediated Gene Delivery and Its Uses

CAS9 mutant genes and polypeptides encoded by same

CELL CLASSIFIER CIRCUITS AND METHODS OF USE THEREOF

DNase H activity of Neisseria meningitidis Cas9

GENOME INTEGRITY ANALYSIS OF VIRUS VECTORS

USE OF EPHB4 AS A TARGET IN SCREENING DRUGS OR MODELS FOR INCREASING INSULIN SENSITIVITY

RNA-guided transcriptional regulation

TARGET-SPECIFIC CRISPR MUTANT

Methods and systems to improve the signal to noise ratio of DNA methylation partitioning assays

NPP1 FUSION PROTEINS

Compositions and methods for treating hemoglobinopathies

HAIRPIN LOOP ENDED SELF-COMPLEMENTARY DOUBLE-STRANDED COVALENTLY CLOSED LINEAR DNA VECTOR, MANUFACTURING SYSTEM AND PROCESS, AND USES OF SAID RESULTING DNA VECTOR

FIELD DEPLOYABLE CRISPR-CAS DIAGNOSTICS AND METHODS OF USE THEREOF

UNIVERSAL DONOR CELLS

STAT3-TARGETED BASE EDITOR THERAPEUTICS FOR THE TREATMENT OF MELANOMA AND OTHER CANCERS

OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS

MODIFIED BACTERIAL RETROELEMENT WITH ENHANCED DNA PRODUCTION

A Method to Produce Targeted Gene Editing Constructs

Guide scaffolds

GENOME EDITING IN SUNFLOWER

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS

Organelle genome modification using polynucleotide guided endonuclease

CRISPR/CAS9 SYSTEM FOR MULTISTRAIN HIV-1 TREATMENT

OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases

RNA EDITOR-ENHANCED RNA TRANS-SPLICING

INTERNAL STANDARD FOR CRISPR GUIDE RNA

NOVEL CRISPR-CAS SYSTEMS FOR GENOME EDITING

Materials and methods for increasing gene editing frequency

Guide RNA combinations and methods of use

Compositions and methods for TTR gene editing and treating ATTR amyloidosis

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

COMPOSITIONS AND METHODS COMPRISING PLANTS WITH REDUCED LIPOXYGENASE AND/OR DESATURASE ACTIVITIES

Compositions and methods for improved gene editing

NUCLEOBASE EDITORS AND METHODS OF USE THEREOF

NUCLEASE-SCAFFOLD COMPOSITION DELIVERY PLATFORM

Optimized CRISPR-Cas nucleases and base editors and methods of use thereof

ACTIVATION OF LYTIC GENES IN CANCER CELLS

COMPOSITIONS AND METHODS FOR MODULATING FORKHEAD BOX P3 (FOXP3) GENE EXPRESSION

CRISPR-Cas NUCLEASES FROM CPR-ENRICHED METAGENOME

METHODS OF INTRODUCING VARIATION INTO PLANTS AND PRODUCTS PRODUCED THEREFROM

NUCLEASE-MEDIATED MODULATION OF GENE EXPRESSION

COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID

Using proteases to control star activity of restriction enzymes

PSEUDOTYPED RECOMBINANT LYSSAVIRUSES FOR GENE THERAPY

GENETICALLY MODIFIED CLOSTRIDIUM BACTERIA, PREPARATION AND USES OF SAME

GENE EDITING METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

DISSEMINATED NEOPLASIA CELLS AND METHODS OF THEIR USE TO CONTROL INVASIVE OR PEST SPECIES

Inducible CRISPR system expression and applications thereof

PRODRUG INCORPORATED sgRNA SYNTHESIS

Systems and Methods to Identify Genetic Silencers and Applications Thereof

CRISPR-Cas13 crRNA Arrays

OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING

COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY

SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME

VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM CELL-TARGETED THERAPY TECHNIQUE

Methods of editing DNA methylation

Inhibition of unintended mutations in gene editing

Polypeptides

Guide RNAs with chemical modification for prime editing

COMPOSITIONS AND METHODS FOR IMPROVING HOMOGENEITY OF DNA GENERATED USING A CRISPR/CAS9 CLEAVAGE SYSTEM

GUIDED EXCISION-TRANSPOSITION SYSTEMS

INTRA-GENOMIC HOMOLOGOUS RECOMBINATION

RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE

Compositions of matter for detection assays

Methods and compositions for prime editing nucleotide sequences

METHODS AND COMPOSITIONS FOR PRODUCTION OF GENETICALLY MODIFIED PRIMARY CELLS

Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA

CELL SPECIFIC, SELF-INACTIVATING GENOMIC EDITING USING CRISPR-CAS SYSTEMS HAVING RNASE AND DNASE ACTIVITY

RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

ODORLESS CANNABIS PLANT

NOVEL TYPE IV AND TYPE I CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

Modified excisable DAS68416-4 soybean transgenic herbicide resistance locus

Sequential gene editing in primary immune cells

BASE EDITOR LACKING HNH AND USE THEREOF

NOVEL DESIGN OF GUIDE RNA AND USES THEREOF

SYSTEMS AND METHODS FOR EVALUATING CAS9-INDEPENDENT OFF-TARGET EDITING OF NUCLEIC ACIDS

METHODS FOR LABELING AND TARGETING CELLS

NOVEL CRISPR-CAS SYSTEMS FOR GENOME EDITING

SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF

COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES

Modified excisable MON87708 soybean transgenic herbicide resistance locus

CRISPR-BASED FOXP3 GENE ENGINEERED T CELLS AND HEMATOPOIETIC STEM CELL PRECURSORS TO TREAT IPEX SYNDROME PATIENTS

COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR COMBINATORIAL ASSEMBLY AND SCREENING FOR FUNCTIONAL SITE-DIRECTED NUCLEOTIDE MODIFIERS

MODIFIED IMMUNE CELLS HAVING ADENOSINE DEAMINASE BASE EDITORS FOR MODIFYING A NUCLEOBASE IN A TARGET SEQUENCE

METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS

COMPOSITIONS AND METHODS FOR GENOME ENGINEERING

Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis

Modified excisable DAS59122-7 maize transgenic locus

METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES

IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS

Modified excisable 5307 maize transgenic locus lacking a selectable marker

Methods and Compositions for Directed Genome Editing

CODON-OPTIMIZED CAS9 ENDONUCLEASE ENCODING POLYNUCLEOTIDE

NOVEL NUCLEOBASE EDITORS AND METHODS OF USING SAME

ENGINEERED CRISPR/CAS13 SYSTEM AND USES THEREOF

CRISPR enzymes and systems

NOVEL PROTOSPACER ADJACENT MOTIF SEQUENCE AND METHOD FOR MODIFYING TARGET NUCLEIC ACID IN GENOME OF CELL BY USING SAME

GENOME EDITING USING CRISPR IN CORYNEBACTERIUM

Recombinant phages comprising transgenes

NOVEL CLASS 2 CRISPR-CAS RNA-GUIDED ENDONUCLEASES

BASIC DOMAIN-DELETED DNASE1-LIKE 3 AND USES THEREOF

THREE-COMPONENT CRISPR/CAS COMPLEX SYSTEM AND USES THEREOF

NUCLEIC ACID SEQUENCE DETECTION BY MEASURING FREE MONORIBONUCLEOTIDES GENERATED BY ENDONUCLEASE COLLATERAL CLEAVAGE ACTIVITY

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

COMPOSITIONS FOR SMALL MOLECULE CONTROL OF PRECISE BASE EDITING OF TARGET NUCLEIC ACIDS AND METHODS OF USE THEREOF

METHOD TO ENHANCE GENE EDITING

Effector proteins and methods of use

TRANSPOSON SYSTEMS FOR GENOME EDITING

PREPARATION METHOD FOR DNA NEXT-GENERATION SEQUENCING LIBRARY

ENGINEERED TARGET SPECIFIC NUCLEASES

Methods and compositions for genomic integration

Applications of engineered Cas9 variants on single-base PAM targets

METHODS TO CHARACTERIZE ENZYMES FOR GENOME ENGINEERING

METHODS AND COMPOSITIONS FOR MODIFYING CYTOKININ RECEPTOR HISTIDINE KINASE GENES IN PLANTS

CELLS HAVING HIGH ADAPTABILITY UNDER HYPOXIC CONDITIONS, AND USE THEREOF

GENETICALLY MODIFIED MEGAKARYOCYTE, MODIFIED PLATELET, AND METHODS RESPECTIVELY FOR PRODUCING SAID GENETICALLY MODIFIED MEGAKARYOCYTE AND SAID MODIFIED PLATELET

COMPOSITION FOR SIMULTANEOUSLY MODIFYING AMINO ACIDS OF SITE 736 AND SITE 738 OF PAPN GENE AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY

METHOD FOR RECOVERING PHAS FROM A BIOMASS

METHODS, COMPOSITIONS AND COMPONENTS FOR CRISPR-CAS9 EDITING OF TGFBR2 IN T CELLS FOR IMMUNOTHERAPY

B cell receptor modification in B cells

TRANSPOSITION-BASED DIAGNOSTICS METHODS AND DEVICES

TWO-STEP GENE SWAP

GENE EDITING SYSTEMS COMPRISING A NUCLEASE AND USES THEREOF

High Fidelity SpCas9 Nucleases for Genome Modification

SWITCHABLE CAS9 NUCLEASES AND USES THEREOF

CRISPR/CAS SYSTEM AND USES THEREOF

ARC-BASED CAPSIDS AND USES THEREOF

ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS

CRISPR DNA targeting enzymes and systems

THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS

CAS9 VARIANTS AND USES THEREOF

CONSTRUCTION OF HIGH-FIDELITY CRISPR/ASCPF1 MUTANT AND USES THEREOF

CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF

METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY

SYNTHETIC GUIDE RNA, COMPOSITIONS, METHODS, AND USES THEREOF

ENGINEERED IMMUNE KILLER CELL, PREPARATION METHOD THEREFOR AND USE THEREOF

INHIBITION OF DENND5B EXPRESSION FOR TREATING HEPATIC STEATOSIS

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

Engineered class 2 type V CRISPR systems

Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S AND USE THEREOF

GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

NUCLEASE CASCADE ASSAY

PROGRAMMABLE ENZYME-ASSISTED SELECTIVE EXPONENTIAL AMPLIFICATION FOR SENSITIVE DETECTION OF RARE MUTANT ALLELES

REGULATABLE EXPRESSION SYSTEMS

GENE EDITING USING A MESSENGER RIBONUCLEIC ACID CONSTRUCT

crRNA:tracrRNA-BASED BINARY LOGIC GATE DESIGN AS A TOOL FOR SYNTHETIC BIOLOGY

Class II, type II CRISPR systems

ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA TUMOR STROMA STABILIZATION

GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES

IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)

A CAS9-PDBD BASE EDITOR PLATFORM WITH IMPROVED TARGETING RANGE AND SPECIFICITY

AFFINITY TAG FOR RECOMBINATION PROTEIN RECRUITMENT

Optimized protein fusions and linkers

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME

ZINC FINGER NUCLEASE VARIANTS FOR TREATING OR PREVENTING LYSOSOMAL STORAGE DISEASES

System for the biocontrol of white spot syndrome virus (WSSV) in aquaculture

TARGETED INTEGRATION IN MAMMALIAN SEQUENCES ENHANCING GENE EXPRESSION

METHODS FOR MANUFACTURING GENETICALLY ENGINEERED CAR-T CELLS

GENETICALLY CORRECTED CELLS FOR THERAPEUTIC USE

COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS

Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells

Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent

TREATMENT OF CHRONIC PAIN

METHODS FOR TARGETED CELL DEPLETION

CRISPR CASCADE ASSAY

Efficient TCR gene editing in T lymphocytes

CRISPR-CAS10 SYSTEMS AND METHODS FOR PHAGE GENOME EDITING

COMPOSITIONS, METHODS, AND SYSTEMS FOR GENOME EDITING TECHNOLOGY

RETROTRANSPOSONS AND USE THEREOF

ND2006 CAS12A mutant genes and polypeptides encoded by same

CRISPR-based programmable RNA editing

DEVELOPMENT OF DUAL-gRNA APPROACH WITH UNDETECTABLE OFF-TARGET EFFECT TO CORRECT C9ORF72 REPEAT EXPANSION AND C9ORF72 PATHOLOGY

COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE

METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM

PROGRAMMABLE DNA NUCLEASE-ASSOCIATED LIGASE AND METHODS OF USE THEREOF

Bioengineered Microbial Spores

Novel Vectors and Uses Thereof

ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF

ENGINEERING CIRCULAR GUIDE RNAS

Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use Thereof

CULTURES OF AND METHODS OF MANUFACTURING SQUAMOUS CELL CARCINOMA CELLS

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING LACTATE DEHYDROGENASE A (LDHA) AND USES THEREOF

Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (ST6GALNAC5) Inhibitors

Methods and products for transfecting cells

COMPOSITIONS AND METHODS FOR THE TARGETING OF RHODOPSIN

USE OF CELLULASE FOR IMPROVEMENT OF SUSTAINABILITY OF DETERGENTS

SYSTEMS AND METHODS FOR LIPID NANOPARTICLE DELIVERY OF GENE EDITING MACHINERY

Modified immune cells having enhanced function and methods for screening for same

COMPOSITIONS AND METHODS FOR THE TARGETING OF HTT

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF

VARIANT CAS9

HSD17B13 VARIANTS AND USES THEREOF

OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME

SPLIT-ENZYME SYSTEM TO DETECT SPECIFIC DNA IN LIVING CELLS

METHOD FOR DETECTING TARGET NUCLEIC ACID, METHOD FOR DETECTING NUCLEIC ACID-BINDING MOLECULE, AND METHOD FOR EVALUATING NUCLEIC ACID-BINDING ABILITY

DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR GENOME EDITING

METHODS AND COMPOSITIONS TO PROMOTING RETINAL REGENERATION USING PROX1 MIGRATION INHIBITOR AS ACTIVE INGREDIENT

Cleaning Compositions comprising Enzymes

DEVICE FOR CONTINUOUSLY PRODUCING AND ANALYZING RNA

CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF

Cas9 as a genome engineering platform with novel PAM specificity

Compositions and methods for organ specific delivery of nucleic acids

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE

CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10)

NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS

SPLIT DEAMINASE BASE EDITORS

METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN

POLYNUCLEOTIDES ENCODING APOA1-RNASE FUSION POLYPEPTIDES

GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF

DELIVERY OF BIOLOGICAL MOLECULES TO PLANT CELLS

REMOVAL OF CONSTRUCTS FROM TRANSFORMED CELLS

METHODS AND COMPOSITIONS INVOLVING CRISPR CLASS 2, TYPE VI GUIDES

COMPOSITIONS AND METHODS FOR EDITING BETA-GLOBIN FOR TREATMENT OF HEMAGLOBINOPATHIES

CAS9 VARIANTS HAVING NON-CANONICAL PAM SPECIFICITIES AND USES THEREOF

MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY

Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity

CRISPR/CAS-MEDIATED GENE CONVERSION

COMPOSITIONS AND METHODS FOR NON-TOXIC CONDITIONING

NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS

ENGINEERED CELLS WITH IMPROVED PROTECTION FROM NATURAL KILLER CELL KILLING

Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing

DNASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF

Polynucleotides, Compositions, and Methods for Polypeptide Expression

METHOD FOR PROVIDING IMMUNE CELLS WITH ENHANCED FUNCTION

LIGATION-BASED GENE EDITING USING CRISPR NICKASE

Application of CAS protein, method for detecting target nucleic acid molecule and kit

ANTI-BACTERIAL CRISPR COMPOSITIONS AND METHODS

CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS

Vitro Cleavage of DNA Using Argonaute

DNA modifying enzymes and active fragments and variants thereof and methods of use

BASE-EDITING SYSTEMS

SUPERNEGATIVELY CHARGED PROTEINS AND USES THEREOF

SELECTIVE EXPANSION OF GENE-TARGETED CELLS

CRISPR AND AAV STRATEGIES FOR X-LINKED JUVENILE RETINOSCHISIS THERAPY

RNA GUIDED ERADICATION OF HUMAN JC VIRUS AND OTHER POLYOMAVIRUSES

DUAL SUPRAMOLECULAR NANOPARTICLE VECTORS ENABLE CRISPR/CAS9-MEDIATED KNOCKIN OF RETINOSCHISIN 1 GENE-A POTENTIAL NON-VIRAL THERAPEUTIC SOLUTIONS FOR X-LINKED JUVENILE RETINOSCHISIS

PROGRAMMABLE NUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF SYNTHESIZING RNA MOLECULES

APPLICATION OF TRANSPORT CARRIER GENE WHICH IMPROVES L-TRYPTOPHAN PRODUCTION EFFICIENCY IN ESCHERICHIA COLI

METHOD OF ENGINEERING HYPOIMMUNOGENIC MUSCLE PRECURSOR CELLS

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

METHOD FOR CONDUCTING SITE-SPECIFIC MODIFICATION ON ENTIRE PLANT VIA GENE TRANSIENT EXPRESSION

ENGINEERED CELLS FOR CONTROLLED PRODUCTION

A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY